Relapsing chronic eosinophilic pneumonia treated successfully with benralizumab.

Ann Allergy Asthma Immunol

Mercer Allergy and Pulmonary Associates, LLC, Trenton, New Jersey.

Published: June 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anai.2021.02.016DOI Listing

Publication Analysis

Top Keywords

relapsing chronic
4
chronic eosinophilic
4
eosinophilic pneumonia
4
pneumonia treated
4
treated benralizumab
4
relapsing
1
eosinophilic
1
pneumonia
1
treated
1
benralizumab
1

Similar Publications

Background: The expected seasonal recurrence of (new variants of) COVID-19 and the emergence of other airborne infectious diseases underscore the need for a sustainable healthcare preparedness strategy. It is particularly essential to ensure equitable access to healthcare for individuals with chronic diseases, including dementia and Parkinson's Disease. Moreover, it is vital to provide clinicians and researchers in the neurodegenerative disease fields with resources and infrastructure to ensure continuity of their work, even during a pandemic.

View Article and Find Full Text PDF

Breast cancer (BC) is one of the leading causes of death and morbidity among women worldwide. Epidemiologic evidence shows that the risk of BC and other chronic diseases decreases as the proportion of whole plant foods increases, while the proportion of animal foods (fish, meat, poultry, eggs, seafood, and dairy products) and non-whole plant foods (e.g.

View Article and Find Full Text PDF

Objective: To explore the perspectives and experiences of patients and carers living with the long-term consequences of pelvic exenteration.

Summary Background Data: Pelvic exenteration is accepted as the standard of care for selected patients with locally advanced or recurrent rectal cancer. With contemporary 5-year survival reported at 40-60%, the number of long-term survivors is expected to increase.

View Article and Find Full Text PDF

Background: We sought to comprehensively describe drug-related components associated with acute kidney injury (AKI) in patients with chronic kidney disease (CKD), describing the incidence of drug-related AKI, the proportion of preventable AKI, identified the various drugs potentially associated with it, explored the risk factors, and assessed the 1-year incidences of the recurrence of drug-related AKI, kidney failure, and death.

Methods: CKD-REIN is a French national prospective cohort of 3033 nephrology outpatients with a confirmed diagnosis of CKD (eGFR <60 ml/min/1.73 m²).

View Article and Find Full Text PDF

Recurrence of chronic lymphatic leukemia as infiltration of the spinal cord.

J Med Life

November 2024

3rd Medical Department, Hanusch Krankenhaus, Vienna, Austria.

Central nervous system (CNS) involvement in chronic lymphocytic leukemia (CLL) is rare, and spinal cord infiltration as a presenting manifestation has only rarely been described. We present the case of a 65-year-old man with CLL, initially diagnosed at the age of 54, who had not received prior treatment. He presented with a six-week history of thoracic and epigastric pressure.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!